Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3


ALP E., ÖNEN H. İ. , YILMAZ A., ÇOBANOĞLU G., GÖKÇE Ö., ÖZKAN A., ...Daha Fazla

Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, 19 - 22 Aralık 2012